Evidence map›Paper›PMID 34205911›Full record

ArticleCells2021

Hypoxia Inducible Factor-1α Attenuates Ischemic Brain Damage by Modulating Inflammatory Response and Glial Activity.

Nashwa Amin, Shijia Chen, Qiannan Ren, Xiaoning Tan, Benson O A Botchway, Zhiying Hu, Fengpei Chen, Shan Ye, Xiaoxue Du, Zuobing Chen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Targeted proteomic analysis identifies ACVRL1 as a marker of cerebral edema in aneurysmal subarachnoid hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Nashwa AminInstitute of Neuroscience, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Shijia ChenInstitute of Neuroscience, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Qiannan RenInstitute of Neuroscience, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Xiaoning TanInstitute of Neuroscience, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Benson O A BotchwayInstitute of Neuroscience, School of Medicine, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0001-9732-7904
Zhiying HuObstetrics & Gynecology Department, Zhejiang Integrated Traditional and Western Medicine Hospital, Hangzhou 310003, China.
Fengpei ChenThe Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 310053, China.
Shan YeThe Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 310053, China.
Xiaoxue DuTranslational Medicine Center, Affiliated Hangzhou First People's Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.
Zuobing ChenDepartment of Rehabilitation Medicine, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.
Marong FangInstitute of Neuroscience, School of Medicine, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-6636-4347
Zhejiang University · CNZhejiang Chinese Medical University · CNHangzhou First People's Hospital · CNIntegrated Chinese Medicine (China) · CN

Funding

National Natural Science Foundation of China 81971769 and 81871063
6 · The paper itself

Abstract

Hypoxia-inducible factor 1 can sufficiently control the progress of neurological symptoms after ischemic stroke owing to their actions associated with its downstream genes. In this study, we evaluated the role of HIF-1α in attenuating brain damage after endothelin-1 injection. Focal cerebral ischemia in mice were induced by endothelin-1 microinjection. Hypoxia-inducible factor 1 activator, dimethyloxalylglycine (DMOG), and HIF-1α inhibitor, acriflavine (ACF), were used to evaluate the hypoxia-inducible factor 1 activity during cerebral ischemia. The expression levels of HIF-1α, glial fibrillary acidic protein (GFAP), interleukin-10 (IL-10), inducible nitric oxide synthase (iNOS), phosphorylated I-kappa-B-alpha/total I-kappa-B-alpha (p-IκBα/IκBα) and nuclear factor kappa B (NF-kB) were assessed. Besides, mRNA levels of IL-10, tumor necrosis factor- alpha (TNF-α), and NF-kB were also analyzed. Results showed a noticeable increase in hypoxia-inducible factor 1 and IL-10 levels in the DMOG group with a decline in iNOS, TNF-α, and NF-kB levels, implying the anti-inflammatory role of hypoxia-inducible factor 1 activator following stroke. These findings were further corroborated by GFAP immunostaining that showed astrocytic activation to be inhibited 12 days post-ischemia, as well as histological and TEM analyses that demonstrated hypoxia-inducible factor 1 induction to alleviate neuronal soma damage and cell death. Based on our study, HIF-1α could be a potential therapeutic target for ischemic stroke.

Indexed as

AnimalsBrain IschemiaCytokinesGlial Fibrillary Acidic ProteinHypoxia-Inducible Factor 1, alpha SubunitInflammationIschemic StrokeMiceNeurogliaNitric Oxide Synthase Type IICytokinesGlial Fibrillary Acidic Proteinglial fibrillary astrocytic protein, mouseHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitNitric Oxide Synthase Type IINos2 protein, mouseacriflavineastrocytedimethyloxalylglycineendothelin-1hypoxia-inducible factor-1interleukin 10proinflammatory cytokines

Identifiers

PMID34205911
PMCPMC8229365
OpenAlexW3168741109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.